Anjum Shahid ( PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi. )
Huma Qureshi ( PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi. )
Sarwar J. Zuberi ( PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi. )
Serum and urinary electrolytes were determined in 34 patients with portal systemic encephalopathy. In coma due to hepatitis, 73% had hyponatraemia, 64% hypokalaemia and 75% low urinary sodium and potassium. In coma due to cirrhosis, 78% had hyponatraemia, 69.5% hypokalaemia, 79% low urinary sodium and potassium levels in serum and urine appear sodium and 53% reduced urinary potassium. Low to bad prognostic findings. (JPMA 35 211, 1985).
Abnormalities in electrolyte metabolism are almost invariable in advanced liver disease.1
Marked renal retention of sodium occurs in fulmiriant hepatic failure and cirrhosis.2-6 Urinary sodium excretion is usually less than 15 meq/24hrs in hepatorenal syndrome.7
Hypokalaemia has also been reported in acute and chronic hepatic failure.8,9
Serum and urinary electrolytes were therefore studied in coma due to hepatitis and cirrhosis.
Material and Methods
Sodium, potassium, chloride and bicarbonate were determined in 34 patients with portal systemic encephalopathy and 100 controls. In 11 cases, coma was due to hepatitis (group 1) and in 23 due to cirrhosis (group II).
Sodium and potassium were determined in both blood and 24 hours urine samples by flame photometry. Serum chloride was determined by mercuric nitrate method’ 0 and serum bicarbonate by micro carbondioxide system, a simplified version of classical Van Slyke method (Harleco kit).
The involvement of the kidney in advanced liver disease has been known. Significant renal insufficiency was found in patients with acute and chronic liver disease. The occurance of renal failure in hepatic disorders carries grave prognosis.1
Abnormal renal retention of sodium is a characteristic finding in both cirrhosis and fulminant hepatic failure.2 Hyponatraemia12 was found in 73% cases of coma due to hepatitis and 78% cases of coma due to cirrhosis. The mortality rate was high in both groups. In cirrhosis with ascites and oedema there is a tendency for water retention along with sodium and thus serum sodium falls because of dilutional effect. It should not be corrected with hypertonic sodium chloride unless there is clear evidence of a profound loss of sodium from the body.13
Metabolic changes commonly associated with portal systemic encephalopathy include hypokalaemia and extracellular alkalosis.14-16 Blood in the gut lowers the serum potassium level by producing an exchange of circulating potassium into the intestinal fluid.17 Serum potassium was low in 64% of groun I and 69.5% cases of group II. Potassium levels were lower in comatose patients in groups I and II than in patients with hepatitis and cirrhosis without coma18 and a value as low as 1.7 meq/L was observed in coma due to cirrhosis. In group II, coma mortality rate was high in mild type of hypokalemia but as the sample number is too small, the result is not conclusive. As hypokal-aemia carries a grave prognosis, prompt and effective measures should be taken to correct itas soon as possible. Potassium chloride supplements must be given both orally and intravenously. If urinary output is normal, at least 120 meq/day are needed.13
Serum sodium when related with serum potassium showed no correlation in coma of both types.
Serum chloride had normal mean values in both groups while serum bicarbonate was normal in coma due to cirrhosis but slightly low in coma due to hepatitis.
Increased renal retention of sodium results from either a reduction in glomerular filtration rate or from an increased rate of tubular reabsorp-tion.19 Patients with hepatic coma are unable to excrete solute free water resulting in excretion of a hypertonic urine devoid of sodium.7 Seventy five percent and 79% cases of group I and II coma respectively had low urinary sodium excretion which is a bad prognostic sign. In group I the level showed wide variation ranging from 0.24- 203 meq/24hrs and the mortality rate was 83%. Group II also showed variation in the level (0.92-559 meq/24 hrs) and in this group the mortality rate was even higher i.e. 93%. In general urinary sodium excretion is a more sensitive indicator.
Potassium is thought to be excreted by an ion exchange for sodium in a distal portion of the nephron.20 The absence of potassium wastage in the presence of increased amounts of aldosterone is explained as the result of nearly complete proximal sodium reabsorption, leaving a sharply reduced amount of sodium in the distal tubule to facilitate potassium excretion.19 Low urinary potassium was found in 75% and 53% cases of group I and II coma and the mortality rate was 66% and 90% respectively.
Thus electrolytes are of significant importance in patients with decompensated liver disease. Hypokalaemia carries grave prognosis and should be corrected immediately. It is presumed that correction might improve the prognosis to a greater extent.
1. Wilkinson, S.P. and Williams, R. Introduction. Postgrad Med. J., 1975; 51: 485.
2. Wilkinson, S.P., Moodie, H., Alain, A, and Williams, R. Renal retention of sodium in cirrhosis and fulminant hepatic failure. Postgrad. Med. J., 1975;51 :527.
3. Farnsworth, E.B., Electrolyte partition in patients with oedema of various origins; sodium and chloride. Am. J.Med.. 1948;4: 338.
4. Eisenmenger, W,I Blondheim, S.H., Bongiovanni, A.M. and Kunkel, H.G. Electrolyte studies on patients with ciirhosis of the liver. J. Clin. Invest., 1950;29: 1491.
5. Faloon, W.W., Eckhardt, R.D., Cooper, A.M. and Davidson, C.S. The effect of human serum albumin, mercurial diuretics, and a low sodium diet on sodium excretion in patients with cirrhosis of the liver. J. Clin. Invest., 1949; 28 : 595.
6. Goldman, R. Studies in diurnal variation of water and electrolyte excretion; nocturnel diuresis of water and sodium in congestive cardiac failure and cirrhosis of the liver. J. Clin. Invest., 1951; 30: 1191.
7. Vaamonde, CA., Vaamonde, L.S., Morosi, H.J., Klingler, E.L. Jr. and Papper,S. Renal concentrating ability in cirrhosis. 1. Changes associated with clinical status and course of the disease. J. Lab. Clin. Med., 1967; 70 : 179.
8. Knell, A.J., Pratt, D.E., Curzon, G., and Williams, R. Changing ideas in hepatic encephalopathy, in eight symposium of advanced medicine. edited by Neale, G. London, Pitman, 1972, p. 156.
9. Artman, L.E. and Wise, A.R. Hypokalaemia in liver cell failure. Am. J. Med., 1953; 15 : 459.
10. Schales, 0. and Schales, S.S. Cited by Varley, H. Practical clinical biochemistry. 4th ed. London, Heinemann, 1967.
11. Shear, L., Keinerman, J. and Gabuzda, GJ. Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am.J.Med., 1965;39: 184.
12. Wilkinson, S.P., Arroyo, V.A., Moodie, H., Blendis, L.M. and Williams, R. Abnormalities of sodium excretion and other disorders of renal function in fuhninant hepatic failure. Gut, 1976; 17: 501.
13. Sherlock, S.Diseases of the liver and biliary system. 6th ed. Oxford, Black well, 1981, p. 126.
14. Chalmer, T.C. Pathogenesis and treatment of hepatic failure. N. Engl. J. Med., 1960; 263:23.
15. Sherlock, S. Pathogenesis and management of hepatic coma. Am. J. Med., 1958; 24: 805.
16. Butt, H.R. and Summerskil, W.H.J. Hepatic coma, in progress in liver aisease. Popper, H. and Schaffner, F. New York, Grune and Stralton, 1961,v. 1: 109.
17. Kukral, J.C., Kerth, J.D., Stefanovic, N., Pancner, R.J, Preston, F.W. and Hanegar, G.C. Metabolic alkalosis, hyperammonemia and meat intoxication following blood gavage in dogs with Eck’s fistula. Surg. Gynaecol. Obstet., 1962; 114 : 431.
18. Shahid, A., Qureshi, H., Nizami, F. and Zuberi, S.J. Electrolytes in liver disease; a preliminary study. JPMA., 1983; 33: 289.
19. Laragh, J .H. and Ames, R2. Physiology of body water and electrolytes in hepatic disease. Med. Clin. North Am., 1963;47 :587.
20. Berliner, LW. Ion exchange mechanism in the nephron. Circulation, 1960; 21: 892.